These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30584363)

  • 1. IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis.
    Browning L; Patel MR; Horvath EB; Tawara K; Jorcyk CL
    Cancer Manag Res; 2018; 10():6685-6693. PubMed ID: 30584363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression.
    Abaurrea A; Araujo AM; Caffarel MM
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.
    Wang L; Zhang F; Cui JY; Chen L; Chen YT; Liu BW
    Oncol Rep; 2018 May; 39(5):2081-2090. PubMed ID: 29565447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation.
    Krzysiek-Maczka G; Targosz A; Szczyrk U; Strzalka M; Brzozowski T; Ptak-Belowska A
    J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 31889044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
    Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
    J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway.
    Subramaniam KS; Omar IS; Kwong SC; Mohamed Z; Woo YL; Mat Adenan NA; Chung I
    Am J Cancer Res; 2016; 6(2):200-13. PubMed ID: 27186396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
    Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer metastases: challenges and opportunities.
    Guan X
    Acta Pharm Sin B; 2015 Sep; 5(5):402-18. PubMed ID: 26579471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.
    Lokau J; Schoeder V; Haybaeck J; Garbers C
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3).
    Sterbova S; Karlsson T; Persson E
    Biochem Biophys Res Commun; 2018 Apr; 498(4):769-774. PubMed ID: 29526757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
    Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
    Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.